Biocon Limited (NSE:BIOCON)
India · Delayed Price · Currency is INR 387.75
-6.15 (-1.56%)
At close: Jan 1, 2026
Biocon Market Cap
Biocon has a market cap or net worth of 517.44 billion as of December 31, 2025. Its market cap has increased by 22.55% in one year.
Market Cap
517.44B
Enterprise Value
684.27B
Revenue
164.76B
Ranking
n/a
PE Ratio
99.28
Stock Price
387.75
Market Cap Chart
Since April 7, 2004, Biocon's market cap has increased from 45.41B to 517.44B, an increase of 1,039.41%. That is a compound annual growth rate of 11.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 1, 2026 | 517.44B | -1.56% |
| Dec 31, 2025 | 525.64B | 20.22% |
| Dec 31, 2024 | 437.25B | 46.69% |
| Dec 29, 2023 | 298.08B | -4.59% |
| Dec 30, 2022 | 312.41B | -27.97% |
| Dec 31, 2021 | 433.73B | -21.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.12T |
| Divi's Laboratories | 1.70T |
| Cipla | 1.21T |
| Apollo Hospitals Enterprise | 1.01T |
| Zydus Lifesciences | 910.24B |
| Mankind Pharma | 900.74B |
| Aurobindo Pharma | 689.00B |
| Fortis Healthcare | 663.46B |